Viewing Study NCT05085561


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-02-24 @ 8:25 AM
Study NCT ID: NCT05085561
Status: COMPLETED
Last Update Posted: 2025-08-06
First Post: 2021-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Sponsor: Recursion Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module